Eric Sheldon

2.3k citations
37 papers · 1.7k · h-index 25

Impact in

  • Epidemiology top 5%
    • Influenza Virus Research Studies
    • Respiratory viral infections research
  • Infectious Diseases top 5%
    • Viral gastroenteritis research and epidemiology
    • SARS-CoV-2 and COVID-19 Research

Papers in

  • Epidemiology 16
    • Influenza Virus Research Studies 11
    • Respiratory viral infections research 2
  • Pharmacology 7
    • Inflammatory mediators and NSAID effects 6
Co-authors
Mark M. Blatter (1 shared paper)Eric Plennevaux (1 shared paper)Martine Denis (1 shared paper)Francis X. Burch (2 shared papers)Louis Fries (4 shared papers)George Risi (4 shared papers)Filip Dubovsky (3 shared papers)Nachiket Patel (1 shared paper)
Journals
Vaccine (13 papers)The Journal of Infectious Diseases (3 papers)Clinical Therapeutics (2 papers)Journal of Pain (2 papers)Current Medical Research and Opinion (2 papers)
Partner nations
United StatesCanadaBelgium

In The Last Decade

Eric Sheldon

37 papers receiving 1.6k citations

Peers

Eric Sheldon
Comparison fields: 5 of 95
  • Epidemiology 720
  • Infectious Diseases 304
  • Pharmacology 269
  • Immunology 268
  • Microbiology 58
Replace Hongmei Xu with:
Hongmei Xu China
T. Söderstrom Sweden
Neena Khanna India
Maureen Bower United States
Rance K. Sellon United States
Claudius U. Meyer Germany
James K. Roche United States
Alfredo Focà Italy
Svend Stenvang Pedersen Denmark
Jo Ellen Schweinle United States
Eric Sheldon relative to Hongmei Xu China Hongmei Xu's profile →
Citations per field
00.5×2×4×6×7.1×
Hongmei Xu · 1×
Citations per year

Countries citing papers authored by Eric Sheldon

Since Specialization
Citations

This map shows the geographic impact of Eric Sheldon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eric Sheldon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eric Sheldon more than expected).

Fields of papers citing papers by Eric Sheldon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eric Sheldon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eric Sheldon. The network helps show where Eric Sheldon may publish in the future.

Co-authors

The 25 scholars most cited alongside Eric Sheldon, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Eric Sheldon Line = papers co-authored together Eric Sheldon links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 37 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Immune response after a single vaccination against 2009 influenza A H1N1 in USA: a preliminary report of two randomised controlled phase 2 trials
The Lancet ·Eric Plennevaux, Eric Sheldon, Mark M. Blatter, Mary-Kate Reeves-Hoché, Martine Denis
2009214
2
Development of VAX128, a recombinant hemagglutinin (HA) influenza-flagellin fusion vaccine with improved safety and immune response
Vaccine ·David N. Taylor, John J. Treanor, Eric Sheldon, Casey Johnson, Scott Umlauf, Langzhou Song, Uma Kavita, Ge Liu, Lynda Tussey, Karen Ozer, Thomas Hofstaetter, Alan Shaw
2012109
3
Treatment of chronic low back pain with etoricoxib, a new cyclo-oxygenase-2 selective inhibitor: improvement in pain and disability—a randomized, placebo-controlled, 3-month trial
Journal of Pain ·C. Birbara, Anthony D Puopolo, David Muñoz, Eric Sheldon, Antoinette Mangione, Norman R. Bohidar, Gregory P. Geba
200393
4
Immunogenicity, reactogenicity and safety of an inactivated quadrivalent influenza vaccine candidate versus inactivated trivalent influenza vaccine: a phase III, randomized trial in adults aged ≥18 years
BMC Infectious Diseases ·Dorothee Kieninger, Eric Sheldon, Wen‐Yuan Lin, Chong‐Jen Yu, José M. Bayas, Julian Gabor, Meral Esen, Jose Luis Fernandez Roure, Silvia Narejos Pérez, Carmen Alvarez Sanchez, Yang Feng, Carine Claeys, Mathieu Peeters, Bruce L. Innis, Varsha Jain
201390
5
Safety and Cross‐Reactive Immunogenicity of Candidate AS03‐Adjuvanted Prepandemic H5N1 Influenza Vaccines: A Randomized Controlled Phase 1/2 Trial in Adults
The Journal of Infectious Diseases ·Joanne M. Langley, Louise Frenette, Linda Ferguson, Dennis Riff, Eric Sheldon, George Risi, Casey Johnson, Ping Li, Richard T. Kenney, Bruce L. Innis, Louis Fries
201079
6
Dose-Sparing H5N1 A/Indonesia/05/2005 Pre-pandemic Influenza Vaccine in Adults and Elderly Adults: A Phase III, Placebo-Controlled, Randomized Study
The Journal of Infectious Diseases ·Joanne M. Langley, George Risi, Michael S. Caldwell, Larry Gilderman, Bruce Berwald, Charles Fogarty, Terry L. Poling, Dennis Riff, Mira Baron, Louise Frenette, Eric Sheldon, Harry Collins, Marc Shepard, Marc Dionne, Daniel Brüne, Linda Ferguson, David W. Vaughn, Ping Li, Louis Fries
201170
7
Lidocaine patch 5% improves pain, stiffness, and physical function in osteoarthritis pain patients
Osteoarthritis and Cartilage ·Francis X. Burch, C. Codding, Nachiket Patel, Eric Sheldon
200468
8
A phase 1, placebo-controlled, randomized study of the safety, tolerability, and immunogenicity of a Clostridium difficile vaccine administered with or without aluminum hydroxide in healthy adults
Vaccine ·Eric Sheldon, Nicholas Kitchin, Yahong Peng, Joseph Eiden, William C. Gruber, Erik W. Johnson, Kathrin U. Jansen, Michael W. Pride, Louise Pedneault
201660
9
Safety, tolerability, and immunogenicity of a 4-antigen Staphylococcus aureus vaccine (SA4Ag): Results from a first-in-human randomised, placebo-controlled phase 1/2 study
Vaccine ·Robert W. Frenck, C. Buddy Creech, Eric Sheldon, David Seiden, Martin Kankam, James Baber, Edward T. Zito, Robin Hubler, Joseph Eiden, Joseph M. Severs, Shite Sebastian, Jasdeep S. Nanra, Kathrin U. Jansen, William C. Gruber, Annaliesa S. Anderson, Douglas Girgenti
201657
10
Randomized, double-blind, placebo-controlled, safety and immunogenicity study of 4 formulations of Anthrax Vaccine Adsorbed plus CPG 7909 (AV7909) in healthy adult volunteers
Vaccine ·Robert J. Hopkins, Nancy Daczkowski, Paulina E. Kaptur, Derek Muse, Eric Sheldon, Craig LaForce, Suha Sari, Thomas L. Rudge, Edward W. Bernton
201357
11
Evaluation of the Comparative Efficacy of Etoricoxib and Ibuprofen for Treatment of Patients With Osteoarthritis: A Randomized, Double-Blind, Placebo-Controlled Trial
Mayo Clinic Proceedings ·Craig W. Wiesenhutter, Judith A. Boice, Amy T. Ko, Eric Sheldon, Frederick T. Murphy, Bret A. Wittmer, Michelle L. Aversano, Alise Reicin
200555
12
Efficacy and tolerability of lumiracoxib in the treatmentof osteoarthritis of the knee: A 13-week, randomized, double-blind comparison with celecoxib and placebo
Clinical Therapeutics ·Eric Sheldon, André Beaulieu, Zorba Paster, Dipen Dutta, Sue Yu, Victor S. Sloan
200554
13
A randomized, double-blind noninferiority study of quadrivalent live attenuated influenza vaccine in adults
Vaccine ·Stan L. Block, Tingting Yi, Eric Sheldon, Filip Dubovsky, Judith Falloon
201153
14
A phase 1a, first-in-human, randomized study of a respiratory syncytial virus F protein vaccine with and without a toll-like receptor-4 agonist and stable emulsion adjuvant
Vaccine ·Judith Falloon, Fei Ji, Craig Curtis, Stephan Bart, Eric Sheldon, Diane Krieger, Filip Dubovsky, Stacie Lambert, Therese Takas, Tonya Villafana, Mark T. Esser
201652
15
Effect of a natural extract of chicken combs with a high content of hyaluronic acid (Hyal-Joint®) on pain relief and quality of life in subjects with knee osteoarthritis: a pilot randomized double-blind placebo-controlled trial
Nutrition Journal ·Douglas Kalman, Maria Heimer, Anita Valdeon, Howard Schwartz, Eric Sheldon
200851
16
Topical lidocaine patch 5% may target a novel underlying pain mechanism in osteoarthritis
Current Medical Research and Opinion ·Bradley S. Galer, Eric Sheldon, Nileshkumar Patel, Chris Codding, Francis X. Burch, Arnold R. Gammaitoni
200450
17
Safety, tolerability, and immunogenicity of a single dose 4-antigen or 3-antigen Staphylococcus aureus vaccine in healthy older adults: Results of a randomised trial
Vaccine ·C. Buddy Creech, Robert W. Frenck, Eric Sheldon, David Seiden, Martin Kankam, Edward T. Zito, Douglas Girgenti, Joseph M. Severs, Frederick W. Immermann, Lisa K. McNeil, David Cooper, Kathrin U. Jansen, William C. Gruber, Joseph Eiden, Annaliesa S. Anderson, James Baber
201649
18
Safety and Long-term Humoral Immune Response in Adults After Vaccination With an H1N1 2009 Pandemic Influenza Vaccine With or Without AS03 Adjuvant
The Journal of Infectious Diseases ·Murdo Ferguson, George Risi, Matthew Davis, Eric Sheldon, Mira Baron, Ping Li, Miguel G. Madariaga, Louis Fries, Olivier Godeaux, David W. Vaughn
201247
19
Comparison of the effectiveness and tolerability of lidocaine patch 5% versus celecoxib for osteoarthritis-related knee pain: Post hoc analysis of a 12 week, prospective, randomized, active-controlled, open-label, parallel-group trial in adults
Clinical Therapeutics ·Alan Kivitz, Michael Fairfax, Eric Sheldon, Qinfang Xiang, Beverly A. Jones, Arnold R. Gammaitoni, Errol Gould
200839
20
Randomized, double-blind, active-controlled study evaluating the safety and immunogenicity of three vaccination schedules and two dose levels of AV7909 vaccine for anthrax post-exposure prophylaxis in healthy adults
Vaccine ·Robert J. Hopkins, Gurdyal Kalsi, Victor Montalvo‐Lugo, Mona Sharma, Yukun Wu, Derek Muse, Eric Sheldon, Frank C. Hampel, Laurence Lemiale
201639

About Eric Sheldon

Eric Sheldon is a scholar working on Epidemiology, Pharmacology, Physiology, Surgery and Molecular Biology, having authored 37 papers that have together received 1.7k indexed citations. Recurring topics across this work include Influenza Virus Research Studies (11 papers), Inflammatory mediators and NSAID effects (6 papers), Pain Mechanisms and Treatments (4 papers), Osteoarthritis Treatment and Mechanisms (3 papers), Bacillus and Francisella bacterial research (3 papers), Poxvirus research and outbreaks (2 papers), Peptidase Inhibition and Analysis (2 papers) and Respiratory viral infections research (2 papers). The work is most often cited by research in Epidemiology (720 citations), Infectious Diseases (304 citations), Pharmacology (269 citations), Immunology (268 citations) and Microbiology (58 citations). Eric Sheldon has collaborated with scholars based in United States, Canada and Belgium. Frequent co-authors include Mark M. Blatter, Eric Plennevaux, Martine Denis, Francis X. Burch, Louis Fries, George Risi, Filip Dubovsky, Nachiket Patel, C. Codding and C. Birbara. Their work appears in journals such as Vaccine, The Journal of Infectious Diseases, Clinical Therapeutics, Journal of Pain and Current Medical Research and Opinion.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hongmei XuBreakdown of academic impact, for papers by T. SöderstromBreakdown of academic impact, for papers by Neena KhannaBreakdown of academic impact, for papers by Maureen BowerBreakdown of academic impact, for papers by Rance K. SellonBreakdown of academic impact, for papers by Claudius U. MeyerBreakdown of academic impact, for papers by James K. RocheBreakdown of academic impact, for papers by Alfredo FocàBreakdown of academic impact, for papers by Svend Stenvang PedersenBreakdown of academic impact, for papers by Jo Ellen Schweinle